The key breakthrough we aim to accomplish in this project is based on specific advantages of graphene: i) its ability to physically penetrate the bacterial biofilm, and ii) its ability to serve as a loading point for large amounts of hydrophobic drugs.
NordForsk is announcing phase two of its call for proposals under the Nordic Programme for Interdisciplinary Research. The top 55 pre-proposals from phase one of the call are being invited to submit full proposals under phase two. The application deadline is 28 May 2020.
NordForsk’s new programme will promote high-quality interdisciplinary research that combines and integrate skills from multiple disciplines. The first call for proposals under the Nordic Programme for Interdisciplinary Research has a budget of NOK 120 million and the deadline for submissions is 13 November 2019.
337. That is the number of pre-proposals generated by NordForsk’s call for interdisciplinary research proposals. The purpose of the NordForsk programme is to encourage high-quality interdisciplinary research, and the call for proposals has a budget of NOK 120 million.
The aim of the NordForsk Programme for Interdisciplinary Research is to promote excellent bottom-up research that combines and integrate skills from multiple disciplines.
NordForsk’s new programme will promote high-quality interdisciplinary research that combines and integrate skills from multiple disciplines. The first call for proposals under the Nordic Programme for Interdisciplinary Research has a budget of NOK 120 million and the deadline for submissions is 13 November 2019.
Major advancements in many fields now make it possible to personalise medical treatment. Still, there are too few products facilitating this in practice, particularly when it comes to treatment that patients themselves carry out at home. The Nordic POP project is looking to change this. “Our goal is to develop pharmaceutical products and technological solutions of the future, where personalised medical treatment is the common link,” says Professor Ingunn Tho of the Nordic POP project and the University of Oslo School of Pharmacy.
